A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)

Clinical trial NCT02302079 · COMPLETED

Trial details

NCT number: NCT02302079
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetic Macular Edema

Start date: 2015-01-12
Primary completion: 2016-08-12
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.